Leadership
TransCode's senior leadership team combines decades of oncology drug discovery and development expertise, life science business acumen and Wall Street knowledge to add both scientific insight and valuable strategic perspective to address cancer and create a sustainable commercialization product pipeline. Our scientists have decades of experience in the foundational areas of RNA and drug development, employing a variety of RNA approaches based on cancer indication and patient needs.